The clinical relevance of cribriform and intraductal prostate cancer in diagnostic needle biopsies

被引:0
|
作者
Kweldam C.F. [1 ]
Kümmerlin I.P. [1 ]
Nieboer D. [2 ]
Verhoef E.I. [1 ]
Steyerberg E.W. [2 ]
Incrocci L. [3 ]
Bangma C.H. [4 ]
van der Kwast T.H. [5 ]
Roobol M.J. [4 ]
van Leenders G.J. [1 ]
机构
[1] afdeling Pathologie, Erasmus Medisch Centrum, Rotterdam
[2] afdeling Maatschappelijke Gezondheidszorg, Erasmus Medisch Centrum, Rotterdam
[3] afdeling Radiotherapie, Erasmus MC Kanker Instituut, Rotterdam
[4] afdeling Urologie, Erasmus Medisch Centrum, Rotterdam
[5] Laboratory Medicine Program, University Health Network, Toronto
关键词
cribriform; intraductal carcinoma; prostate cancer;
D O I
10.1007/s13629-016-0163-y
中图分类号
学科分类号
摘要
Cribriform and intraductal prostate cancer are both associated with an adverse outcome after radical prostatectomy. We included all patients with prostate cancer from the first screening round of the European Randomized Study of Screening for Prostate Cancer (ERSPC). All available slides were revised and scored for presence of cribriform and/or intraductal prostate cancer. Outcome measurements were biochemical recurrence and disease-specific survival. In total, 486 patients had Gleason score (GS) 6 (47%) and 545 GS ≥7 (53%). The disease-specific survival and biochemical-recurrence-free survival of CR/IDC−-GS3+4 patients did not differ significantly from those with GS 6, while patients with CR/IDC+-GS3+4-patients had a significant poorer outcome. Conclusion: The presence of cribriform and intraductal growth in prostate cancer, is a strong clinical prognostic marker with potential. The use of this variable in a clinical setting could contribute to reducing overtreatment of prostate cancer. © 2017, The Author(s).
引用
收藏
页码:168 / 177
页数:9
相关论文
共 50 条
  • [31] Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
    Lozano, Rebeca
    Salles, Daniela C.
    Sandhu, Shahneen
    Aragon, Isabel M.
    Thorne, Heather
    Lopez-Campos, Fernando
    Rubio-Briones, Jose
    Gutierrez-Pecharroman, Ana M.
    Maldonado, Laneisha
    di Domenico, Tomas
    Sanz, Alejandro
    Prieto, Juan D.
    Garcia, Isabel
    Pacheco, Maria, I
    Garces, Teresa
    Llacer, Casilda
    Romero-Laorden, Nuria
    Zambrana, Francisco
    Lopez-Casas, Pedro P.
    Lorente, David
    Mateo, Joaquin
    Pritchard, Colin C.
    Antonarakis, Emmanuel S.
    Olmos, David
    Lotan, Tamara L.
    Castro, Elena
    EUROPEAN JOURNAL OF CANCER, 2021, 147 : 74 - 83
  • [32] Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
    Bottcher, Rene
    Kweldam, Charlotte F.
    Livingstone, Julie
    Lalonde, Emilie
    Yamaguchi, Takafumi N.
    Huang, Vincent
    Yousif, Fouad
    Fraser, Michael
    Bristow, Robert G.
    van der Kwast, Theodorus
    Boutros, Paul C.
    Jenster, Guido
    van Leenders, Geert J. L. H.
    BMC CANCER, 2018, 18
  • [33] Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate
    Hickman, Richard A.
    Yu, Hui
    Li, Jianhong
    Kong, Max
    Shah, Rajal B.
    Zhou, Ming
    Melamed, Jonathan
    Deng, Fang-Ming
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (04) : 550 - 556
  • [34] Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
    René Böttcher
    Charlotte F. Kweldam
    Julie Livingstone
    Emilie Lalonde
    Takafumi N. Yamaguchi
    Vincent Huang
    Fouad Yousif
    Michael Fraser
    Robert G. Bristow
    Theodorus van der Kwast
    Paul C. Boutros
    Guido Jenster
    Geert J. L. H. van Leenders
    BMC Cancer, 18
  • [35] Molecular transcript profiling in formalin fixed paraffin embedded diagnostic prostate cancer needle biopsies
    Rogerson, L.
    Darby, S.
    Jabber, T.
    Robson, C.
    O'toole, K.
    Leung, H.
    Mathers, M.
    Sahadevan, K.
    Gnanapraciasarth, V
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 225 - 225
  • [36] Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations
    Hesterberg, Amanda B.
    Gordetsky, Jennifer B.
    Hurley, Paula J.
    UROLOGY, 2021, 155 : 47 - 54
  • [37] On cribriform prostate cancer
    Kweldam, Charlotte F.
    van der Kwast, Theodorus
    van Leenders, Geert J.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (01) : 145 - 154
  • [38] Atypical Cribriform Lesions of the Prostate Are Often Localized in the Vicinity of High Grade Cancer and Have a Similar Clinical and Pathological Significance as Intraductal Carcinoma of the Prostate
    Yu, Hui
    Kong, Max
    Hickman, Richard
    Zhou, Ming
    Melamed, Jonathan
    Deng, Fang-Ming
    MODERN PATHOLOGY, 2015, 28 : 269A - 270A
  • [39] Inflammatory atrophy in prostate needle biopsies: Relationship to cancer?
    Billis, A
    Freitas, LLL
    Magna, L
    Ferreira, U
    LABORATORY INVESTIGATION, 2006, 86 : 131A - 131A
  • [40] Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4
    Chen, Zhengshan
    Pham, Huy
    Abreu, Andre
    Amin, Mahul B.
    Sherrod, Andy E.
    Xiao, Guang-Qian
    Aron, Manju
    HUMAN PATHOLOGY, 2021, 118 : 18 - 29